Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV

NCT02016924 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Acquired Immune Deficiency Syndrome (AIDS)
HIV Infections

Interventions

DRUG: ATV
DRUG: DRV
DRUG: Cobicistat
DRUG: BR
DRUG: F/TAF
DRUG: LPV/r
DRUG: Third Unboosted Drug
DRUG: Cobicistat TOS
DRUG: F/TAF TOS

Sponsor

Gilead Sciences